Search hospitals

>

New Mexico

>

Albuquerque

Presbyterian Kaseman Hospital

Claim this profile

Albuquerque, New Mexico 87110

Global Leader in Breast Cancer

Global Leader in Breast cancer

Conducts research for Lung Cancer

Conducts research for Non-Small Cell Lung Cancer

Conducts research for Cancer

80 reported clinical trials

12 medical researchers

Photo of Presbyterian Kaseman Hospital in AlbuquerquePhoto of Presbyterian Kaseman Hospital in AlbuquerquePhoto of Presbyterian Kaseman Hospital in Albuquerque

Summary

Presbyterian Kaseman Hospital is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Presbyterian Kaseman Hospital is involved with conducting 80 clinical trials across 201 conditions. There are 12 research doctors associated with this hospital, such as Atul Kumar, Carolyn Y. Muller, Ursa A. Brown-Glaberman, and Neda Hashemi Sadraei.

Area of expertise

1

Breast Cancer

Global Leader

Presbyterian Kaseman Hospital has run 34 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
ER positive
HER2 negative
2

Breast Cancer

Global Leader

Presbyterian Kaseman Hospital has run 25 trials for Breast cancer. Some of their research focus areas include:

Stage IV
ER positive
HER2 negative

Top PIs

Clinical Trials running at Presbyterian Kaseman Hospital

Lung Cancer

Breast Cancer

Bladder Cancer

Uterine Cancer

Breast cancer

Multiple Myeloma

Cancer

Colorectal Cancer

Pancreatic Cancer

Lymphoma

Image of trial facility.

High-Dose Radiation + Chemotherapy and Immunotherapy

for Non-Small Cell Lung Cancer

This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.

Recruiting

2 awards

Phase 3

14 criteria

Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Presbyterian Kaseman Hospital?